Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 5
2005 4
2006 1
2007 1
2009 5
2010 3
2011 14
2012 9
2013 9
2014 11
2015 20
2016 29
2017 37
2018 35
2019 41
2020 35
2021 62
2022 14
Text availability
Article attribute
Article type
Publication date

Search Results

287 results
Results by year
Filters applied: . Clear all
Page 1
Liver cirrhosis.
Ginès P, Krag A, Abraldes JG, Solà E, Fabrellas N, Kamath PS. Ginès P, et al. Lancet. 2021 Oct 9;398(10308):1359-1376. doi: 10.1016/S0140-6736(21)01374-X. Epub 2021 Sep 17. Lancet. 2021. PMID: 34543610 Review.
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C infection, autoimmune diseases, cholestatic diseases, and iron o …
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such as obesity, non-alcoholic fatty
Hepatocellular carcinoma.
Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, Gores G. Llovet JM, et al. Nat Rev Dis Primers. 2016 Apr 14;2:16018. doi: 10.1038/nrdp.2016.18. Nat Rev Dis Primers. 2016. PMID: 27158749 Free article. Review.
Liver cancer is the second leading cause of cancer-related deaths globally and has an incidence of approximately 850,000 new cases per year. ...Additional risk factors such as non-alcoholic steatohepatitis are also emerging. Advances in the understandi
Liver cancer is the second leading cause of cancer-related deaths globally and has an incidence of approximately 850,000 new cases pe
Burden of liver diseases in the world.
Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Asrani SK, et al. J Hepatol. 2019 Jan;70(1):151-171. doi: 10.1016/j.jhep.2018.09.014. Epub 2018 Sep 26. J Hepatol. 2019. PMID: 30266282 Review.
Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due to complications of cirrhosis and 1million due to viral hepatitis and hepatocellular carcinoma. ...About 2 billion people consume alcohol worldwide and upwards of 75 million
Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due to complications of cirrhosis and
Evolution of NAFLD and Its Management.
Mundi MS, Velapati S, Patel J, Kellogg TA, Abu Dayyeh BK, Hurt RT. Mundi MS, et al. Nutr Clin Pract. 2020 Feb;35(1):72-84. doi: 10.1002/ncp.10449. Epub 2019 Dec 16. Nutr Clin Pract. 2020. PMID: 31840865 Review.
The global prevalence of nonalcoholic fatty liver disease (NAFLD) is estimated to be 25% and continues to rise worldwide in the setting of the obesity epidemic. This increase is especially concerning because NAFLD is often a progressive disease that ca …
The global prevalence of nonalcoholic fatty liver disease (NAFLD) is estimated to be 25% and continues to rise worldwid …
Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis.
Gaul S, Leszczynska A, Alegre F, Kaufmann B, Johnson CD, Adams LA, Wree A, Damm G, Seehofer D, Calvente CJ, Povero D, Kisseleva T, Eguchi A, McGeough MD, Hoffman HM, Pelegrin P, Laufs U, Feldstein AE. Gaul S, et al. J Hepatol. 2021 Jan;74(1):156-167. doi: 10.1016/j.jhep.2020.07.041. Epub 2020 Aug 4. J Hepatol. 2021. PMID: 32763266 Free PMC article.
We also examined a cohort of 154 adult patients with biopsy-proven non-alcoholic fatty liver disease (Sir Charles Gairdner Hospital, Nedlands, Western Australia). ...The activated form of caspase-1 was detected in the livers and in serum from pa …
We also examined a cohort of 154 adult patients with biopsy-proven non-alcoholic fatty liver disease (Sir …
Nonalcoholic Fatty Liver Disease.
Wang XJ, Malhi H. Wang XJ, et al. Ann Intern Med. 2018 Nov 6;169(9):ITC65-ITC80. doi: 10.7326/AITC201811060. Ann Intern Med. 2018. PMID: 30398639 Review.
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. ...Cardiovascular disease is the leading cause of death in patients with nonalcoholic fatty liver disease. ...
Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease. ...Cardiovascular …
Pathology of liver disease: advances in the last 50 years.
Torbenson M, Washington K. Torbenson M, et al. Hum Pathol. 2020 Jan;95:78-98. doi: 10.1016/j.humpath.2019.08.023. Epub 2019 Sep 4. Hum Pathol. 2020. PMID: 31493428 Review.
Liver disease has been recognized in various forms for centuries. ...With these tools, pathologists and their clinical and basic science colleagues moved from classifying liver disease using an observational, pattern-based approach to a refined classif
Liver disease has been recognized in various forms for centuries. ...With these tools, pathologists and their clinical and bas
Nuclear receptors and nonalcoholic fatty liver disease.
Cave MC, Clair HB, Hardesty JE, Falkner KC, Feng W, Clark BJ, Sidey J, Shi H, Aqel BA, McClain CJ, Prough RA. Cave MC, et al. Biochim Biophys Acta. 2016 Sep;1859(9):1083-1099. doi: 10.1016/j.bbagrm.2016.03.002. Epub 2016 Mar 4. Biochim Biophys Acta. 2016. PMID: 26962021 Free PMC article. Review.
Several of these receptors including the peroxisome proliferator-activated receptors (PPARs), the pregnane and xenobiotic receptor (PXR), the constitutive androstane receptor (CAR), the liver X receptor (LXR) and the farnesoid X receptor (FXR) are key regulators of the gut …
Several of these receptors including the peroxisome proliferator-activated receptors (PPARs), the pregnane and xenobiotic receptor (PXR), th …
Cellular senescence drives age-dependent hepatic steatosis.
Ogrodnik M, Miwa S, Tchkonia T, Tiniakos D, Wilson CL, Lahat A, Day CP, Burt A, Palmer A, Anstee QM, Grellscheid SN, Hoeijmakers JHJ, Barnhoorn S, Mann DA, Bird TG, Vermeij WP, Kirkland JL, Passos JF, von Zglinicki T, Jurk D. Ogrodnik M, et al. Nat Commun. 2017 Jun 13;8:15691. doi: 10.1038/ncomms15691. Nat Commun. 2017. PMID: 28608850 Free PMC article.
The incidence of non-alcoholic fatty liver disease (NAFLD) increases with age. Cellular senescence refers to a state of irreversible cell-cycle arrest combined with the secretion of proinflammatory cytokines and mitochondrial dysfunction. ...Mec …
The incidence of non-alcoholic fatty liver disease (NAFLD) increases with age. Cellular senescence refers …
Endoplasmic reticulum stress in liver disease.
Malhi H, Kaufman RJ. Malhi H, et al. J Hepatol. 2011 Apr;54(4):795-809. doi: 10.1016/j.jhep.2010.11.005. Epub 2010 Nov 13. J Hepatol. 2011. PMID: 21145844 Free PMC article. Review.
Faced with persistent ER stress, adaptation starts to fail and apoptosis occurs, possibly mediated through calcium perturbations, reactive oxygen species, and the proapoptotic transcription factor CHOP. The UPR is activated in several liver diseases; including obesity asso …
Faced with persistent ER stress, adaptation starts to fail and apoptosis occurs, possibly mediated through calcium perturbations, reactive o …
287 results